EDSIVO™ Publications and Presentations

EDSIVO™ Publications and Presentations

Society for Vascular Medicine 2019 Annual Scientific Sessions  Tetali et al  May 2019
Pilot Study to Evaluate Effect of Antihypertensive Therapy on the Rates of Clinical Events in Patients with Vascular Ehlers-Danlos Syndrome

Journal of the American College of Cardiology 2019; 73:194857  Frank Peer Reviewed Publication

Audio summary by Editor-in-Chief of JACC, Dr. Valentin Fuster

Vascular Ehlers-Danlos Syndrome: Publication

Vascular Ehlers-Danlos Syndrome: Long-Term Observational Study


Lancet 2010; 376: 1476-84  Ong  Peer Reviewed Publication

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial

NORD Poster Presentation  Grabowsky  October 2018

Big Data Analytics to Estimate Prevalence of Ehlers-Danlos Syndrome

(Vascular Phenotype) and Rate of Rupture Events

Cardiology in Review 2017; 25: 247-253  Nawarskas  Peer Reviewed Publication

Celiprolol, A Unique Selective Adrenoceptor Modulator

Genetics in Medicine 2014; 16(12): 881-8  Pepin  Peer Reviewed Publication

Survival is affected by mutation type and molecular mechanism in vascular EhlersDanlos syndrome (EDS type IV)

Cardiovascular Research 2019; cvz095  Dubacher  Peer Reviewed Publication

Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers Danlos syndrome